Scroll down
Home / Business case / R&D agreements in Life Sciences

R&D agreements in Life Sciences

20 March 2020

Health/pharma, therapeutic area

Assistance of a biotech company which designs and develops vectors facilitating the targeting and delivery of therapeutic or imaging agents during the negotiation of a strategic R&D and licensing agreement in the field of the treatment of neurodegenerative pathologies with the subsidiary of a global big pharma.


Close assistance in the negotiation of all contractual aspects, particularly sensitive intellectual property clauses, with a view of preventing and limiting litigation risks.


Conclusion of a strategic agreement for the company: this partnership falls into the client’s strategy to use its technology to conclude R&D agreements with biopharmaceutical companies. The objective is to create new patentable chemical entities based on the vectorization of its partners’ drug candidates.

Other Business Cases

Subscribe to
our newsletter